Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|July 19, 2017
PEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia <sup>†</sup>Caitlin R Rausch, Bernard L Marini, Lydia L Benitez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 18, 2009
Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejectionSusan M Faust, Guanyi Lu, Bernard L Marini, et al.
Leukemia & Lymphoma|November 7, 2017
Pegasparaginase silent inactivation during therapy for NK/T cell lymphomaDeeter R Neumann, Bernard L Marini, Tycel J Phillips, et al.
Leukemia & Lymphoma|November 20, 2019
Optimal sequence of daratumumab and elotuzumab in relapsed and refractory multiple myelomaEmily Hoylman, Anna Brown, Anthony J Perissinotti, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 7, 2025
It's "Blin" a Long Time Coming: The Rise of Blinatumomab in Philadelphia Chromosome-Negative Acute Lymphoblastic LeukemiaLauren T Shinn, Madeleine A King, Julia Brown, et al.
Leukemia Research|February 9, 2021
Impact of high dose cytarabine dosing strategies in obese patients with acute myeloid leukemiaMadeleine A Ochs, Anthony J Perissinotti, Bernard L Marini, et al.
Annals of Hematology|July 22, 2023
Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoringTaylor D Coe-Eisenberg, Anthony J Perissinotti, Bernard L Marini, et al.
Annals of Hematology|May 26, 2022
Oncology stewardship in acute myeloid leukemiaMadeleine A Ochs, Bernard L Marini, Anthony J Perissinotti, et al.
Pageof 7